Neurogene NGNE
NASDAQ NGNE
$27.82 -0.57 (-2.01%)
At close: Sep 30, 2026 · 4:00 PM EDT

Neurogene (NGNE) Asset Utilization Ratio (2019 - 2025)

Updated

Neurogene's Asset Utilization Ratio came in at 0.00 for Q2 2025, down 38.8% from 0.00 a year earlier.

Analysis

Neurogene (NGNE) Asset Utilization Ratio (2019 - 2025) Analysis & Trends

Going back to Q3 2019, Neurogene's Asset Utilization Ratio data covers 8 quarters.

  • The Q2 2025 figure represents the lowest quarterly Asset Utilization Ratio in data going back to Q3 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 0.49
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 0.47
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 0.52
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 0.44
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 0.53
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 0.40
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 0.58
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 0.47
10 Neurogene 640.25 Mn 640.25 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 0.00
Dec 31, 2024 0.00
Sep 30, 2024 0.01
Jun 30, 2024 0.00
Dec 31, 2023 6.41
Sep 30, 2023 10.89
Jun 30, 2023 10.39
Sep 30, 2019 14.28
API Access

Neurogene Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=NGNE&period=max&api_key=YOUR_API_KEY